comparemela.com

Page 10 - Tourmaline Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Analysts Issue Forecasts for Tourmaline Bio, Inc s FY2026 Earnings (NASDAQ:TRML)

Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued to investors on Thursday, December 7th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($4.00) per share for the year. Leerink Partnrs […]

New yorkUnited statesPiper sandlerLeerink partnrsCaley casteleinSandeep chidambar kulkarniTourmaline bio company profileTourmaline bio incSecurities exchange commissionTourmaline bioFree reportTruist financialBio stock downGet free reportChidambar kulkarniExchange commission

Top stocks to watch on Wall Street on Thursday

Here are the biggest calls on Wall Street on Thursday.

United statesTinto citiRaymond jamesWells fargoMorgan stanleyAmazon web servicesGoldman sachsWall streetPrime videoRio tinto citiChinese new yearConstellation brandsBest ideaGrand theftPure storageMatch group

Sandeep Chidambar Kulkarni Purchases 4,000 Shares of Tourmaline Bio, Inc (NASDAQ:TRML) Stock

Sandeep Chidambar Kulkarni Purchases 4,000 Shares of Tourmaline Bio, Inc (NASDAQ:TRML) Stock
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSandeep chidambar kulkarniPiper sandlerTourmaline bio incTourmaline bioGet free reportChidambar kulkarniThyroid eye diseaseTourmaline bio daily

Tourmaline Bio, Inc (NASDAQ:TRML) Director Buys $17,310 00 in Stock

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) Director Parvinder Thiara bought 1,000 shares of Tourmaline Bio stock in a transaction dated Friday, November 17th. The stock was purchased at an average price of $17.31 per share, with a total value of $17,310.00. Following the purchase, the director now directly owns 83,782 shares in the […]

New yorkUnited statesPiper sandlerParvinder thiaraSecurities exchange commissionTourmaline bio incTourmaline bio company profileTourmaline bioGet free reportDirector parvinder thiaraExchange commissionThyroid eye diseaseTourmaline bio dailyNasdaq trmlInsider tradingNsider trades

Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Truist Financial

Truist Financial initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The firm issued a buy rating and a $43.00 target price on the stock. TRML has been the topic of several other reports. Piper Sandler assumed coverage on shares of […]

New yorkUnited statesPiper sandlerCaley casteleinAaron kantoffSecurities exchange commissionTourmaline bio company profileTourmaline bio incTruist financialTourmaline bioFree reportDirector caley casteleinExchange commissionDirector aaron kantoffGet free reportThyroid eye disease

vimarsana © 2020. All Rights Reserved.